Does PANTOPRAZOLE Cause Rebound acid hypersecretion? 1,581 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,581 reports of Rebound acid hypersecretion have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 2.0% of all adverse event reports for PANTOPRAZOLE.
1,581
Reports of Rebound acid hypersecretion with PANTOPRAZOLE
2.0%
of all PANTOPRAZOLE reports
226
Deaths
195
Hospitalizations
How Dangerous Is Rebound acid hypersecretion From PANTOPRAZOLE?
Of the 1,581 reports, 226 (14.3%) resulted in death, 195 (12.3%) required hospitalization, and 15 (0.9%) were considered life-threatening.
Is Rebound acid hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 1,581 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE Cause?
Chronic kidney disease (28,127)
Acute kidney injury (15,961)
Renal failure (11,543)
End stage renal disease (8,523)
Renal injury (7,070)
Drug ineffective (5,487)
Off label use (4,279)
Pain (4,057)
Dyspnoea (4,052)
Fatigue (3,797)
What Other Drugs Cause Rebound acid hypersecretion?
ESOMEPRAZOLE (2,501)
OMEPRAZOLE (2,350)
LANSOPRAZOLE (1,713)
DEXLANSOPRAZOLE (1,160)
OMEPRAZOLE\SODIUM BICARBONATE (95)
RABEPRAZOLE (64)
RANITIDINE (29)
FAMOTIDINE (12)
ESOMEPRAZOLE\NAPROXEN (9)
Which PANTOPRAZOLE Alternatives Have Lower Rebound acid hypersecretion Risk?
PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS
PANTOPRAZOLE vs PANTOTHENIC ACID
PANTOPRAZOLE vs PAPAVERINE
PANTOPRAZOLE vs PARACETAMOL
PANTOPRAZOLE vs PARATHYROID HORMONE